2(35) 2013

DOI xxxxxxxx

Lugovskiy S. P.1, Lubyanova I. P.2, Klimenko P. P.3

PECULIARITY OF IRON METABOLISM AND ITS ROLE IN CARCINOGENESIS PROCESSES

1SI «Ukrainian Institute of Industrial Medicine of Ministry of Health of Ukraine», Kryvyi Rig
2SI «Institute for Occupational Health of NAMS of Ukraine», Kyiv
3SI «Institute of Gerontology of NAMS of Ukraine», Kyiv

Full article (PDF), RUS

New date on the role in cancer development are presented in the paper, including, also, those of occupational health. Key chains of iron metabolism, causing the effect on the viability and proliferative activity of cells have been defined. Using the date, laid down in the paper, will help to improve risk assessment and prognosis of the development of malignant tumors, diagnostics, prophylaxis and treatment of workers, exposed to iron or its compounds.

Key words: iron metabolism, carcinogenesis, occupational cancer

References

  1. IARC Monographs on the evaluation of carcinogenic risks to humans (Internet. Report 08/001) / Report of the advisory group to recommend priorities for IARC: Monographs during 2010-2014 - [Electronic resource] - Mode of access: http://monographs.iarc.fr/ENG/Publications/internrep/08-001.pdf.- Title from the screen.
  2. Perelik rechovyn, produktiv, vyrobnychykh protsesiv, pobutovykh ta pryrodnykh faktoriv, kantserohennykh dlya lyudyny. Hihiyenichnyy normatyv: HN 1.1.2.123-2006. [Chynnyy vid 13-01-2006].- k., 2006. [Elektronnyy resurs] - Rezhym dostupu:: http://zakon.nau.ua/doc/?code = z0100-06..
  3. Les maladies professionnelles: régime general - INRS, 2012. [Electronic resource] - Mode of access: http://www.inrs.fr/accueil/produits/bdd/mp.html.- Title from the screen.
  4. Mikroelementozy cheloveka: etiologiya, klassifikatsiya, organopatologiya / Avtsyn A. P., Zhavoronkov A. a., Rish M. a., Strochkova L. S.- M.: Meditsina, 1991.- 496 s.
  5. Serebrov A. I. Professional'nyye novoobrazovaniya / Serebrov A. I., Danetskaya O. l.- L. : Meditsina, 1976.- 104 s.
  6. Raykhman YA. G. Upravleniye kantserogennoy situatsiyey i profilaktika raka (sistemnyy podkhod) / Raykhman YA. G., Nilyudin V. a.- Elista: Dzhangar, 1999.- 270 s.
  7. Ishchenko L.O., Lugovskyi S.P., Sidak E.R. (2010), “Epidemiological analysis of the incidence of malignant neoplasm in the population of the radon-dangerous Krivoy Rog iron ore region”, Hihiyena naselenykh mest, Issue 56, 379-384.
  8. Lubyanova I.P., Novichenko N.L.(1995), “On the issue of carcinogenic risk in the profession of a steel welder”, Vrachebnoye delo,4, 88-91.
  9. Characteristics and modifying factors of asbestos- induced oxidative DNA damage // Jiang L., Nagai H., Ohara H. [et al.] // Cancer Sci.- 2008.- V. 99, No 11.- P 2142-2151.
  10. Growth promotion of transformed cells by iron in serum-free culture / Basset P, Zwiller J., Revel M. O. [et al.] // Carcinogenesis.- 1985.- V. 6, No 3.- R 355-359.
  11. Theil E. C. Ferritin: Structure, Gene Regulation, and Cellular Function in Animals, Plants, and Microorganisms / Theil E. C. // Annu. Rev. Biochem.- 1987.- V. 56.- P 289-315.
  12. Belous A. A. Fiziologicheskaya rol' zheleza / Belous A. A., Konnik K. T.- K.: Nauk. dumka, 1991.104 s.
  13. Toyokuni Sh. Role of iron in carcinogenesis: cancer as a ferrotoxic disease / Toyokun Sh. // Cancer Sci.- 2009.- V. 100, No 1 - R 9-16.
  14. Wang S. J. Advancement of the study on iron metabolism and regulation in tumor cells / Wang S. J., Gao C., Chen B. A. // Chin. J. Cancer.- 2010.- V 29, No 4.- P 451-455.
  15. Bohnsack B. L. Nutrient regulation of cell cycle progression / Bohnsack B. L., Hirschi К. K. // Annu. Rev. Nutr- 2004.- No 24.- P. 433-453.
  16. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators / Nyholm S., Mann G. J., Johansson A. G. [et al.] // J. Biol. Chem.- 1993.- V 268, No 35.- P. 26200-26205.
  17. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase / Cooper С. E., Lynagh G. R., Hoyes К. P. [et al.] // J. Biol. Chem.- 1996.- V. 271, No 34.- P. 20291­20299.
  18. Witt L. Regulation of ribonucleotide reductase activity and its possible exploitation in chemotherapy / Witt L., Yap T, Blakley R. L. // Adv. Enzyme Regul.- 1978.-No 17.- P. 157-171.
  19. Torti S. V. Ironing out cancer / Torti S. V., Torti F. M. // Cancer Res.- 2011.- V. 71, No 5.- P. 1511-1514.
  20. Lubyanova I.P. (2010), “Modern views on iron metabolism from the position of a pathologist”, Aktualnye problemy sovremennoi meditsiny, 2, 47-57.
  21. Frazzon J. Biosynthesis of iron-sulphur clusters is a complex and highly conserved process / Frazzon J., Fick J. R., Dean D. R. // Biochem. Soc. Trans.- 2002.- V. 30, No 4.- P. 680-685.
  22. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis / Furukawa T, Naitoh Y., Kohno H. [et al.].- 1992.- V. 50, No 26.- P. 2059-2065.
  23. Le N. T. The role of iron in cell cycle progression and the proliferation of neoplastic cells / Le N. T., Richardson D. R. // Biochem. Biophys. Acta.- 2002.- V. 1603, No 1.- P 31-46.
  24. Rouault T. A. iron-sulfur cluster biogenesis and human disease / Rouault T A., Tong W. H. // Trends. Genetics.- 2008.- V. 24, No 8.- P 398-407.
  25. Weinberg E. D. Iron out-of-balance: a risk factor for acute and chronic diseases / Weinberg E. D. // Hemoglobin - 2008.- V. 32, No 1-2.- P 117-122.
  26. Body iron metabolism and pathophysiology of iron overload / Kohgo Y, Ikuta K., Ohtake T [et al.] // Int. J. Hematol.- 2008.- V. 88, No 1.- P 7-15.
  27. Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In Vivo / Radulescu S., Matthew J. B., Pedro Salgueiro [et al.] // Cell Reports.- 2012.- V. 2, No 2.- P 270-282.
  28. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation / Ganz T // Blood.- 2003.- V 102.- P 783-788.
  29. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney / Kulaksiz H., Theilig F., Bachmann S. [et al.] // J. Endocrinol.- 2005.- V. 184.- P 361-370.
  30. Hepcidin: from discovery to differential diagnosis / Kemna E. H, Tjalsma H., Willems H. L. [et al.] // Haematologica - 2008.- V. 93, No 1.- P. 90-97.
  31. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity / Krause A., Neitz S., Magert H. J. [et al.] // FEBS Letters - 2000.-V 480.- P. 147-150.
  32. Hepcidin expression and iron transport in alveolar macrophages / Nguyen N. B., Callaghan K. D., Ghio A. J. [et al.] // Am. J. Physiol. Lung Cell. Mol. Physiol.- 2006.-V 291.- P. 417-425.
  33. Ganz T. Hepcidin. A regulator of intestinal iron absorption and iron recycling by macrophages / Ganz T. // Best. Pract. Res. Clin. Haematol - 2005.- V. 18.- P 171-82.
  34. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin / Nemeth E., Rivera S., Gabayan V. [et al.] // J. Clin. Invest.- 2004.- V 113, No 9.- P 1271-1276.
  35. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS / Kemna E., Pickkers R, Nemeth E. [et al.] // Blood.- 2005.- V. 106, No 5.- P 1864-1866.
  36. Gepsidin kak regulyator gomeostaza zheleza / Levina A. A., Kazyukova T. V., Tsvetayeva N. V. [i dr.] // Pediatriya - 2008.- T. 87, No 1.- S. 67-74.
  37. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization / Nemeth E., Tuttle M., Powelson J. [et al.] // Science - 2004.- V. 306, No 5704.- P. 2090-2093.
  38. Weiss G. Anemia of Chronic Disease / Weiss G., Goodnough L. T // N. Engl. J. Med.- 2005.- V. 352.- P 1011-1023.
  39. Serum hepcidin: reference ranges and biochemical correlates in the general population / Galesloot T E., Vermeulen S. H., Geurts-Moespot A. J. [et al.] // Blood.- 2011.- V. 117, No 25.- P 218-225.
  40. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein / Nemeth E., Valore E. V., Territo M. [et al.] // Blood - 2003.- V. 101, No 7.- R 2461-2463.
  41. Ganz T. Hepcidin and iron regulation, 10 years later / Ganz T // Blood - 2011.- V. 117.- R 4425-4433.
  42. In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin / Guangjun N., Guohua Ch., Sheftel A. D. [et al.] // Blood - 2006.- V. 108, No 7.- R. 2428-2434.
  43. Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts / Chen G., Fillebeen C.,WangJ., Rantopoulos K. // Carcinogenesis.- 2007.- V. 28, No 4.- R 785-791.
  44. Ratledge C. Iron, mycobacteria and tuberculosis/ Ratledge C. // Tuberculosis (Edinb.) - 2004.- V. 84, No 1-2.- R 110-130.
  45. Chung J. Copper-induced ferroportin-1 expression in J774 macrophages is associated with increased iron efflux / Chung J., Haile D. J., Wessling- Resnick M. // Rroc. Natl. Acad. Sci. USA - 2004.- V. 101, No 9.- R 2700-2705.
  46. Lee D. W. Iron Dysregulation and Neurodegeneration / Lee D. W., Andersen J. K., Kaur D. // Mol. Interv.- 2006.- V. 6, No 2.- R 89-97.
  47. Benhar M. ROS, Stress-activated kinase and stress signaling in cancer / Benhar M., Engelberg D., Levitzki A. // EMBO reports.- 2002.- V. 3, No 5.- R 420-425.
  48. Jackson A. L. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer / Jackson A. L., Loeb L. A. // Mutat. Res.- 2001.- V. 477, No 1-2.- R 7-21.
  49. Szatrowski T R. Production of large amounts of hydrogen peroxide by human tumor cells / Szatrowski T R, Nathan C. F. // Cancer Res.- 1991.- V. 51, No 3.- R 794-798.
  50. Gupta A. Increased ROS levels contribute to elevated transcription factor and MAR kinase activities in malignantly progressed mouse keratinocyte cell lines / Gupta A., Rosenberger S. F., Bowden G. T // Carcinogenesis.- 1999.- V. 20, No 11.- R 2063-2073.
  51. Epidermal growth factor (EGF) – induced generation of hydrogen peroxide. Role in EGF receptor- mediated tyrosine phosphorylation / Bae Y. S.,Kang S. W., Seo M. S. [et al.] // J. Biol. Chem.- 1997.- V. 272, No 1.- R 217-221.
  52. Rlatelet-derived growth factor-induced H(2)0(2) production requires the activation of phosphatidylinositol 3-kinase / Bae Y. S., Sung J. Y, Kim O. S [et al.] // J. Biol. Chem.- 2000.- V. 275, No 14.- R 10527-10531.
  53. Nitric oxide-mediated inactivation of mammalian ferrochelatase in vivo and in vitro: possible involvement of the iron-sulphur cluster of the enzyme / Furukawa T.,Kohno H., Tokunaga R. [et al.] // Biochem. J.- 1995.- V. 310.- R 533-540.
  54. Hamza I. Intracellular trafficking of porphyrins / Hamza I. // ACS Chem. Biol.- 2006.- V. 1, No 11.- P. 627-629.
  55. Iron and porphyrin trafficking in heme biogenesis / Schultz I. J., Chen C., Raw B. H., Hamza I. // J. Biol. Chem.- 2010.- V 285, No 35.- P. 26753-26759.
  56. Torti F. M. Regulation of ferritin genes and protein / Torti F. M., Torti S. V. // Blood - 2002.- V. 99, No 11.- P. 3505-3516.
  57. Hintze K. J. Cellular regulation and molecular interactions of the ferritins. [Electronic resource] / Hintze K. J., Theil E.C. // Cell. Mol. Life Sci.- 2005.­25.- Mode of access: http://www.chori.org/Rrincipal_Investigators/Theil_ Elizabeth_ C/Downloaables/CMLS %20Hintze %202_06.pdf.- Title from the screen.
  58. Dre2, a conserved eukaryotic Fe/S cluster protein, functions in cytosolic Fe/S protein biogenesis / Zhang Y., Lyver E. R., Nakamaru-Ogiso E. [et al.] // Mol. Cell. Biol.- 2008.- V. 28, No 18.- P. 5569-5582.
  59. Oshiro S. Dysrégulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis [Electronic resource] / Oshiro S., Morioka M. S., Kikuchi M. // Adv. Pharmacol. Scien.- 2011.- V. 2011.- 8 p.- Mode of access: http://wwwhindawi.com/Journals/aps/2011/ 378278/ - Title from the screen.
  60. Ovchinnikov L. P. Chto i kak zakodirovano v mRNK / Ovchinnikov L. P. // Sorosovskiy obrazovat. zhurn.- 1998.- No 4.- S. 10-18.
  61. Levi S. The role of iron in mitochondrial function / Levi S., Rovida E. // Biochim. Biophys. Acta.- 2009.- V. 1790, No 7.- P. 629-36.
  62. De Moura M. B. Mitochondrial dysfunction in neurodegenerative diseases and cancer / de Moura M. B., dos Santos L. S., Van Houten B. // Environ. Mol. Mutagen.- 2010.- V. 51, No 5.- P. 391-405.
  63. Mitochondria in hematopoiesis and hematological diseases / Fontenay M., Cathelin S., Amiot M. [at el.] // Oncogene.- 2006.- V. 25, No 34.- P. 4757-4767.
  64. Kagan J. Mitochondria as a target for early detection and diagnosis of cancer / Kagan J., Srivastava S. // Crit. Rev. Clin. Lab. Sci.- 2005.- V. 42, No 5-6.- R 453-472.
  65. Do alterations in mitochondrial DNA play a role in breast carcinogenesis? / Rohan T. E., Wong L. J., Wang T [at el.] // J. Oncol.- 2010 - V. 2.- P. 1-11.
  66. Ristow M. Oxidative metabolism in cancer growth / Ristow M. // Curr. Opin. Clin. Nutr. Metab. Care- 2006.- V. 9, No 4.- P. 339-345.
  67. King A. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer / King A., Selak M. A., Gottlieb E. // Oncogene.- 2006.- V. 25, No 34.- P. 4675-4682.
  68. Inhibitory effects of nitric oxide on invasion of human cancer cells / Wang F., Zhang R., Xia T. [et al.] // Cancer Lett.- 2007.- V 257, No 2.- R 274-282.
  69. Frataxin participates to the hypoxia-induced response in tumors / Guccini I., Serio D., Condo I. [et al.] // Cell Death.- 2011.- V. 24.- R. el23.- Mode of access: http://www.nature.com/cddis/journal/v2/n2/pdf/cddis20115a. pdf. - Title from the screen.
  70. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice / Thierbach R., Schulz T J., Isken F. [et al.] // Hum Mol Genet.- 2005.- V. 14, No 24.- R 3857-3864.
  71. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU / Favaro E., Ramachandran a., McCormick R. [et al.] // PLoS One.- 2010.- V. 5, No 4.- P. 1—11.
  72. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation / Huang X., Ding L., Bennewith K. L. [et al.] // Mol Cell.- 2009.- V. 35, No 6.- P. 856-867.
  73. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma / Lawrie C. H., Gal S., Dunlop H. M. [et al.] // Br. J. Haematol.- 2008.- V. 141, No 5.- P. 672-675.
  74. Rouault T. A. The role of iron regulatory proteins in mammalian iron homeostasis and disease / Rouault T. A. // Nat. Chem. Biol.- 2006.- V. 2, No 8.- P. 406-414.